Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Pharmacyclics

AZ confirms interest in Acerta takeover

AZ confirms interest in Acerta takeover Acalabrutinib is a Bruton's tyrosine kinase (Btk) inhibitor in the same class as Janssen/Pharmacyclics/Abbvie's Imbruvica (ibrutinib), which is on course to become a $1bn product this year ... Ibrutinib is tipped to become a $5bn-plus product at peak,

Servier announces job cuts as pressures mount

Servier announces job cuts as pressures mount Servier has also had some pipeline setbacks of late. Last year the company abandoned development of its HDAC inhibitor abexinostat for cancer, returning rights to Pharmacyclics, while in October it walked

J&J's share buyback 'doesn't prevent acquisitions'

J&J's share buyback 'doesn't prevent acquisitions' Such a move would be popular with investors who are keen to see the company put that money to good use, particularly after a reported bid for its Imbruvica partner Pharmacyclics

Imbruvica filed as first-line leukaemia therapy

Imbruvica filed as first-line leukaemia therapy Study shows improved progression-free survival. Janssen and Pharmacyclics have filed an application in the US for Imbruvica as a first-line therapy for chronic lymphocytic leukaemia (CLL) which - if approved - ... CLL. The results showed that treatment

Horizon launches $3bn hostile bid for Depomed

Horizon launches $3bn hostile bid for Depomed Horizon's bid comes as the value of M&A activity in the pharma sector is spiking in the first half of 2015, led by AbbVie's $21bn takeover of Pharmacyclics,

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Lucid Group Communications Limited

WE’RE ON A MISSION To enhance patients’ lives through communication that changes behaviour and improves patient health outcomes....

Latest intelligence

The other side of … rheumatoid arthritis
For Georgie, patient activation fuelled her motivation to find life without pain. So when blood tests came back normal, she felt confident to pursue referral until RA was confirmed......
How to lessen site burden with a targeted patient recruitment strategy
Picture this: you’ve created your patient recruitment strategy and you find more and more patients are undertaking the pre-screening, you probably think – success! But then you find out, getting...
Peter Howarth
Exploring the potential of eosinophils
GSK’s Peter Howarth talks about the emerging research that suggests there is a varied role for eosinophils...

Infographics